Gene · 3818
Papers2,245
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,245
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulation. | J Biol Chem | 2025 | 39706265 | PubTator, text mining | PubMed |
| Dissolved organic carbon can alter coastal sediment phosphorus dynamic: Effects of different carbon forms and concentrations. | Chemosphere | 2025 | 39662842 | PubTator, text mining | PubMed |
| Discovery of potent and selective factor XIa inhibitors incorporating triazole-based benzoic acid as novel P2' fragments: Molecular dynamics simulations and anticoagulant activity. | Eur J Med Chem | 2025 | 39580913 | PubTator, text mining | PubMed |
| Structure-based design and synthesis of novel FXIa inhibitors targeting the S2' subsite for enhanced antithrombotic efficacy. | Mol Divers | 2025 | 39514169 | PubTator, text mining | PubMed |
| Unveiling the potential role of virus-encoded polyphosphate kinases in enhancing phosphorus removal in activated sludge systems. | Water Res | 2025 | 39476778 | PubTator, text mining | PubMed |
| CRISPR-Based Therapy for Hereditary Angioedema. | N Engl J Med | 2025 | 39445704 | PubTator, text mining | PubMed |
| Identifying Potential Drug Targets for Keloid: A Mendelian Randomization Study. | J Invest Dermatol | 2025 | 38797322 | PubTator, text mining | PubMed |
| Predictive Ppk calculations for biologics and vaccines using a Bayesian approach - a tutorial. | Pharm Stat | 2025 | 38603591 | PubTator, text mining | PubMed |
| Efficacy and safety of Donidalorsen in Hereditary Angioedema with C1 inhibitor deficiency: a systematic review and a meta analysis. | Arch Dermatol Res | 2024 | 39666085 | PubTator, text mining | PubMed |
| Advent of oral medications for the treatment of hereditary angioedema. | Clin Transl Allergy | 2024 | 39331535 | PubTator, text mining | PubMed |
| Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study. | J Neurol | 2024 | 39264442 | PubTator, text mining | PubMed |
| Enhancing the performance of microalgal-bacterial systems with sodium bicarbonate: A step forward to carbon neutrality of municipal wastewater treatment. | Water Res | 2024 | 39217640 | PubTator, text mining | PubMed |
| [Analysis of two consanguineous Chinese pedigrees affected with Hereditary prokallikrein deficiency and High molecular weight kininogen deficiency]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39217484 | PubTator, text mining | PubMed |
| The trajectory of vesicular proteomic signatures from HBV-HCC by chitosan-magnetic bead-based separation and DIA-proteomic analysis. | J Extracell Vesicles | 2024 | 39207047 | PubTator, text mining | PubMed |
| Realising gene therapy: a biomedical challenge. | EBioMedicine | 2024 | 39152007 | PubTator, text mining | PubMed |
| Phenotypic and genomic characterization of phosphate-solubilizing rhizobia isolated from native Mimosa and Desmodium in Brazil. | Braz J Microbiol | 2024 | 39134912 | PubTator, text mining | PubMed |
| Macrocyclic Inhibitors Targeting the Prime Site of the Fibrinolytic Serine Protease Plasmin. | ChemMedChem | 2024 | 39118493 | PubTator, text mining | PubMed |
| Acute inhibitory effects of tire wear particles on the removal of biological phosphorus：The critical role of aging in improving environmentally persistent free radicals. | Environ Pollut | 2024 | 39089474 | PubTator, text mining | PubMed |
| Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization. | Immunol Allergy Clin North Am | 2024 | 38937015 | PubTator, text mining | PubMed |
| Unveiling therapeutic frontiers: DON/DRP-104 as innovative Plasma kallikrein inhibitors against carcinoma-associated hereditary angioedema shocks - a comprehensive molecular dynamics exploration. | Cell Biochem Biophys | 2024 | 38869687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3818/papers?page=4